The clock-drawing test in elderly Italian community dwellers: Associations with sociodemographic status and risk factors for vascular cognitive impairment

Dementia and Geriatric Cognitive Disorders

Volumn 16, Issue 4, 2003, Pages 287-295

  Ravaglia, Giovanni ^a   Forti, P ^a   Maioli, F ^a   Arnone, G ^a   Pantieri, G ^a   Cocci, C ^a   Nativio, V ^a   Muscari, A ^a   Pedone, V ^b   Mariani, E ^c  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b MAGGIORE HOSPITAL   (Italy)

^c RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

Clock drawing test; Elderly; Frailty; Inflammatory biomarkers; Risk factors; Vascular cognitive impairment

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE;

ACCURACY; ADULT; AGE; AGED; ANAMNESIS; ARTICLE; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; COMMUNITY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DOCUMENTATION; DRAWING; EDUCATION; FEMALE; GERIATRIC PATIENT; GLUCOSE BLOOD LEVEL; HUMAN; LIFESTYLE; MALE; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SCORING SYSTEM; SOCIAL ASPECT; TASK PERFORMANCE;

AGED; AGED, 80 AND OVER; CEREBROVASCULAR DISORDERS; COGNITION DISORDERS; DATA COLLECTION; DEMOGRAPHY; FEMALE; HUMANS; ITALY; MALE; MASS SCREENING; NEUROPSYCHOLOGICAL TESTS; RESIDENCE CHARACTERISTICS; RISK FACTORS; TASK PERFORMANCE AND ANALYSIS;

EID: 0141839749     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000072815     Document Type: Article

References (36)

1. Shulman KI: Clock drawing: Is it the ideal cognitive screening test? Int J Geriatr Psychiatry 2000;15:548-561.
2. Eccles M, Clarke J, Livingstone M, Freemantle N, Mason J: North of England evidence-based guidelines development project: Guideline for the primary care management of dementia. BMJ 1998;317:802-808.
3. Richardson HE, Glass JN: A comparison of scoring protocols on the clock-drawing test in relation to ease of use, diagnostic group, and correlations with Mini-Mental State Examination. J Am Geriatr Soc 2002;50:169-173.
4. Ferrucci L, Cecchi F, Guralnik JM, et al: Does the clock-drawing test predict cognitive decline in older persons independent of the Mini-Mental State Examination? J Am Geriatr Soc 1996;44:1326-1331.
5. Bowler JV: The concept of vascular cognitive impairment. J Neurol Sci 2002;203-204:11-15.
6. Royal DR, Mulroy AR, Chiodo LK, Polk MJ: Clock drawing is sensitive to executive control: A comparison of six methods. J Gerontol B Psychol Sci 1999;54:P328-P333.
7. Ainslie NK, Murden RA: Effect of education on the clock-drawing dementia screen in non-demented elderly persons. J Am Geriatr Soc 1993;41:249-252.
8. Paganini-Hill, Henderson VW: The effects of hormone replacement therapy, lipoprotein cholesterol levels, and other factors on a clock-drawing task in older women. J Am Geriatr Soc 1996;44:818-822.
9. Paganini-Hill A, Clark LJ, Henderson VW, Birge SJ: Clock drawing: Analysis in a retirement community. J Am Geriatr Soc 2001;49:941-947.
10. Polidori MC, Marvardi M, Cherubini A, Senin U, Mecocci P: Heart disease and vascular risk factors in the cognitively impaired elderly: Implications for Alzheimer's disease. Aging (Milano) 2001;13:231-239.
11. Ravaglia G, Forti P, Maioli F, et al: Conselice Study: A population-based study of brain aging in a municipality of the Emilia Romagna Region: Conselice, A.U.S.L. Ravenna. Design and methods. Arch Gerontol Geriatr 2001;33(suppl 1):325-331.
12. Ravaglia G, Forti P, Maioli F, et al: Education, occupation, and prevalence of dementia: Findings from the Conselice Study. Dement Geriatr Cogn Disord 2002;14:90-100.
13. Valente C, Maione P, Lippi A, et al: Validation of the Mini-Mental State Examination (MMSE) as a screening instrument for dementia in an Italian Population. Giorn Gerontol 1992;40:161-165.
14. Sunderland T, Hill JL, Mellow AM, et al: Clock drawing in Alzheimer's disease: A novel measure of dementia severity. J Am Geriatr Soc 1989;37:725-729.
15. Wolf-Klein GP, Silverstone FA, Levy AP, et al: Screening for Alzheimer disease by clock drawing. J Am Geriatric Soc 1989;37:730-734.
16. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chron Dis 1987;40:373-383.
17. Yesavage JA, Brink TL, Rose TL, et al: Development and validation of a geriatric depression screening scale: A preliminary report. J Psychiatr Res 1983;17:37-49.
18. Lynch J, Kaplan GA, Shema SJ: Cumulative impact of sustained economic hardship on physical, cognitive, psychological, and social functioning. N Engl J Med 1997;337:1889-1895.
19. Therapeutics and Technology Assessment Sub-comittee of the American Academy of Neurology. Assessment: Neuropsychological testing of adults: Considerations for neurologists. Arch Clin Neuropsychol 2001;16:255-269.
20. Tombaugh TN, McIntyre NJ: The Mini-Mental State Examination: A comprehensive review. J Am Geriatr Soc 1992;40:922-935.
21. Siu AL: Screening for dementia and investigating its causes. Ann Intern Med 1991;115:122-132.
22. Lawton MP, Brody EM: Assessment of older people: Self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179-185.
23. McDowell I: Alzheimer's disease: Insights from epidemiology. Aging (Milano) 2001;13:143-162.
24. Breteler MMB: Vascular risk factors for Alzheimer's disease: An epidemiologic perspective. Neurobiol Aging 2000;21:153-160.
25. Korczyn AD: The complex nosological concept of vascular dementia. J Neurol Sci 2002;203-204:3-6.
26. MacKnight C, Rockwood K, Awalt E, McDowell I: Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging. Dement Geriatr Cogn Disord 2002;14:77-83.
27. Messier C, Gagnon M: Glucose regulation and brain aging. J Nutr Health Aging 2000;4:208-213.
28. Ridker PM, Stampfer MJ, Rifai N: Novel risk factors for systemic atherosclerosis. JAMA 2001;285:2481-2485.
29. Pearson TA: New tools for coronary risk assessment. What are their advantages and limitations? Circulation 2002;105:886-892.
30. Reuben DB, Cheh AI, Harris TB: et al: Peripheral blood markers of inflammation predict mortality and functional decline in high-functioning community-dwelling older persons. J Am Geriatr Soc 2002;50:638-644.
31. in 't' Veld BA, Ruitenberg A, Hofman A, et al: Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med 2001;345:1515-1521.
32. Cimprich B, Ronis DL: Attention and symptom distress in women with and without breast cancer. Nurs Res 2001;50:86-94.
33. Paganini-Hill A, Clark LJ: Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen. Breast Cancer Res Treat 2000;64:165-167.
34. Selhub J: Folate, vitamin B12 and vitamin B6 and one carbon metabolism. J Nutr Health Aging 2002;6:39-42.
35. Calvaresi E, Bryan J: B vitamins, cognition, and aging. J Gerontol B Psychol Sci 2001;56:P327-P339.
36. Kirby M, Denihan A, Bruce I, Coakley D, Lawlor BA: The clock-drawing test in primary care: Sensitivity in dementia detection and specificity against normal and depressed elderly. Int J Geriatr Psychiatry 2001;16:935-940.